Skip to main content

Table 3 Clinical outcomes of bleeding control

From: Hemostatic efficacy and safety of the hemostatic powder UI-EWD in patients with lower gastrointestinal bleeding

Variables Conventional therapy (n = 112) UI-EWD therapy (n = 55) P-value
Success of immediate hemostasis, n (%) 112 (100%) 55 (100%)  
Cumulative re-bleeding, n (%)
At 7 days 14 (12.5) 3 (5.5) 0.157
At 14 days 16 (14.3) 3 (5.5) 0.091
At 28 days 19 (17.0) 3 (5.5) 0.039
Time to re-bleeding (days)§ 5 (1–25) 4 (1–5)  
Adverse event, n (%)
Colonic obstruction 0 (0.0) 0 (0.0) -
Perforation 1 (0.9) 0 (0.0) -
Infection 1 (0.9) 0 (0.0) 0.448+
Embolization 0 (0.0) 0 (0.0) -
  1. §Median (range)
  2. +Fisher’s exact test
  3. *P-values were calculated using the t-test or Fisher calculated using the of the conventional therapy group and the UI-EWD therapy group